Xiaohu Zheng

6.2k total citations · 3 hit papers
41 papers, 4.2k citations indexed

About

Xiaohu Zheng is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Xiaohu Zheng has authored 41 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 16 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Xiaohu Zheng's work include Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (8 papers). Xiaohu Zheng is often cited by papers focused on Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (8 papers). Xiaohu Zheng collaborates with scholars based in China, United States and Croatia. Xiaohu Zheng's co-authors include Haiming Wei, Binqing Fu, Yonggang Zhou, Xiaoling Xu, Zhigang Tian, Rui Sun, Dongsheng Wang, Wei Sun, Tiantian Li and Mingfeng Han and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Xiaohu Zheng

40 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effective treatment of severe COVID-19 patients with tocilizumab

2020 1.9k citations Xiaoling Xu, Mingfeng Han et al. Proceedings of the National Academy of Sciences profile →
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

2020 814 citations Yonggang Zhou, Binqing Fu et al. profile →
SIRT3 ‐dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth

2023 152 citations Lin Bai, Dongyao Wang et al. EMBO Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaohu Zheng China	22	2.2k	1.3k	989	946	742	41	4.2k
Binqing Fu China	27	2.3k 1.0×	1.3k 1.0×	2.2k 2.2×	958 1.0×	723 1.0×	62	5.4k
Yonggang Zhou China	30	2.2k 1.0×	1.3k 1.0×	919 0.9×	2.7k 2.8×	666 0.9×	79	6.0k
Da Huang China	16	2.6k 1.2×	1.5k 1.2×	473 0.5×	818 0.9×	496 0.7×	78	4.0k
Vincent W. Li United States	13	2.5k 1.1×	1.4k 1.1×	420 0.4×	705 0.7×	730 1.0×	26	4.3k
Gang Xu China	24	1.5k 0.7×	655 0.5×	945 1.0×	1.3k 1.3×	326 0.4×	72	3.7k
Meifang Han China	23	2.9k 1.3×	1.6k 1.2×	739 0.7×	693 0.7×	480 0.6×	59	4.9k
Bicheng Zhang China	25	929 0.4×	468 0.4×	509 0.5×	822 0.9×	813 1.1×	97	2.8k
Mark Kuehnel Germany	15	2.7k 1.2×	1.5k 1.1×	473 0.5×	661 0.7×	634 0.9×	35	4.4k
Qiu Zhao China	31	2.3k 1.0×	1.2k 0.9×	369 0.4×	1.2k 1.3×	1.1k 1.4×	102	5.1k

Countries citing papers authored by Xiaohu Zheng

Since Specialization

Citations

This map shows the geographic impact of Xiaohu Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohu Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohu Zheng more than expected).

Fields of papers citing papers by Xiaohu Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohu Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohu Zheng. The network helps show where Xiaohu Zheng may publish in the future.

Co-authorship network of co-authors of Xiaohu Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohu Zheng. A scholar is included among the top collaborators of Xiaohu Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohu Zheng. Xiaohu Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Manman, Duo Jin, Kaiming Cao, et al.. (2024). Enhancing Tumor Immunotherapy by Multivalent Anti‐PD‐L1 Nanobody Assembled via Ferritin Nanocage. Advanced Science. 11(20). e2308248–e2308248. 20 indexed citations

Bai, Lin, Dongyao Wang, Wei Ding, et al.. (2023). SIRT3 ‐dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Reports. 24(5). e56052–e56052. 152 indexed citations breakdown →

Shen, Yiqing, Xiaohu Zheng, Yeben Qian, et al.. (2023). Interactions between driver genes shape the signaling pathway landscape and direct hepatocellular carcinoma therapy. Cancer Science. 114(6). 2386–2399. 8 indexed citations

Wang, Dong, Xiaohui Li, Defeng Jiao, et al.. (2023). LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. Journal of Hematology & Oncology. 16(1). 30–30. 49 indexed citations

Bi, Jiacheng, Chen Huang, Chao Zhong, et al.. (2023). Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8⁺ T Cells. Advanced Science. 10(12). e2207499–e2207499. 14 indexed citations

Bi, Jiacheng, Chen Huang, Yingying Huang, et al.. (2023). TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells. Journal for ImmunoTherapy of Cancer. 11(2). e006002–e006002. 13 indexed citations

Zheng, Xiaohu, Yeben Qian, Yongwei Zhang, et al.. (2023). Tumors evade immune cytotoxicity by altering the surface topology of NK cells. Nature Immunology. 24(5). 802–813. 57 indexed citations

Du, Xianghui, Huaiping Zhu, Defeng Jiao, et al.. (2022). Human-Induced CD49a+ NK Cells Promote Fetal Growth. Frontiers in Immunology. 13. 821542–821542. 24 indexed citations

Zheng, Xiaohu, Yingchao Dou, Xianghui Du, et al.. (2021). Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells. Clinical Cancer Research. 27(21). 6026–6038. 43 indexed citations

10.

Jiao, Defeng, Xiaohu Zheng, Xianghui Du, et al.. (2021). Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy. Cancer Immunology Immunotherapy. 71(6). 1403–1417. 5 indexed citations

11.

Sun, Zimin, Huilan Liu, Xiaoyu Zhu, et al.. (2021). Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients. Nature Communications. 12(1). 4137–4137. 11 indexed citations

12.

Zhou, Yonggang, Jinhe Zhang, Dongyao Wang, et al.. (2021). Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. Journal of Autoimmunity. 118. 102596–102596. 21 indexed citations

13.

Xu, Xiaoling, Mingfeng Han, Tiantian Li, et al.. (2020). Effective treatment of severe COVID-19 patients with tocilizumab. Proceedings of the National Academy of Sciences. 117(20). 10970–10975. 1874 indexed citations breakdown →

14.

Zhang, Xin, Dong Wang, Zhidong Li, et al.. (2020). Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer. Frontiers in Immunology. 11. 331–331. 51 indexed citations

15.

Jiang, Yong, Xiaohu Zheng, Defeng Jiao, et al.. (2019). Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma. EBioMedicine. 40. 422–431. 11 indexed citations

16.

Cong, Jingjing, Xianwei Wang, Xiaohu Zheng, et al.. (2018). Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression. Cell Metabolism. 28(2). 243–255.e5. 276 indexed citations

17.

Zheng, Xiaohu, Binqing Fu, Meijuan Zheng, et al.. (2016). EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance. Cancer Research. 77(2). 482–493. 24 indexed citations

18.

Li, Young, Yang Wu, Xiaohu Zheng, et al.. (2016). Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine Secretion. Frontiers in Immunology. 7. 569–569. 30 indexed citations

19.

Zheng, Xiaohu, Min Cheng, Binqing Fu, et al.. (2015). Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis. Cancer Research. 75(6). 1080–1090. 26 indexed citations

20.

Zheng, Xiaohu, Zhigang Tian, & Haiming Wei. (2015). Lung specific X protein as a novel therapeutic target for lung cancer. OncoImmunology. 4(12). e1052931–e1052931. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact